Introduction and Objective: Asian Indians have increased insulin resistance, more rapid β-cell decline & higher T2D risk. Early interventions targeting these factors can prevent T2D. We compared the effects of a low carbohydrate, low saturated fat (LC) diet to a high unrefined carbohydrate, low fat (HC) diet on β-cell function, insulin sensitivity & fat distribution […]
Read MoreCategory: Diabetes
1207-P: Associations of Glycemia, Vitamin D, and Physical Activity with Bone Mineral Density (BMD) in Youth with Type 1 Diabetes (T1D)
Introduction and Objective: Bone fragility is a recognized complication of T1D, with previous studies reporting conflicting associations with glycemia. We aimed to evaluate BMD and to identify factors associated with BMD in youth with T1D.Methods: This cross-sectional analysis included youth aged 8-17 years with T1D for ≥1 years. Total body less head (TBLH) BMD was […]
Read More2161-LB: Caloric Restriction Ameliorates MAFLD by Upregulating CREB1-Dependent GSTM3 Expression and Enhancing Mitochondrial Function
Introduction and Objective: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent chronic liver disease linked to obesity and metabolic disorders. Caloric restriction (CR) and intermittent fasting (IF) improve metabolic health, but their effects on MAFLD and underlying mechanisms are unclear. This study compared CR and IF regimens in MAFLD models and explored the role […]
Read More1130-P: Improving the Accuracy of Influenza Vaccination Status Documentation for Patients with Diabetes—A Quality Improvement Project
Introduction and Objective: Efforts to improve influenza vaccination rates among patients with diabetes can be enhanced with accurate documentation of vaccination status in the electronic medical record (EMR). This quality improvement project aimed to identify factors contributing to inaccurate vaccination status in the EMR documentation.Methods: Ambulatory patients with diabetes presenting for routine follow up were […]
Read More2160-LB: Long-Acting Exendin 4 Protein Enhances Insulin Secretion and Improves Steatotic Liver in High-Fat Diet–Fed Mice
Introduction and Objective: Exendin-4 (Ex-4) is a glucagon-like peptide-1 receptor agonist used for the treatment of type 2 diabetes and other metabolic disorders, including steatotic liver disease. However, its short half-life necessitates multiple daily injections, resulting in poor patient compliance, limited efficacy, and increased treatment costs. To address this problem, we introduce a novel drug […]
Read More466-P: Exploration of Single Nucleotide Polymorphisms Associated with Small-Fiber Neuropathy
Introduction and Objective: Introduction & Objective: Small fiber neuropathy (SFN) is known to develop early in the course of diabetic polyneuropathy (DPN). It has been shown that single nucleotide polymorphisms (SNPs) are involved in DPN, but how SNPs correlate with SFN has not yet been investigated. In the present study, we explored the correlation in […]
Read More215-OR: Increased White Adipose Tissue Oxidative Capacity and Insulin Resistance Are Early Changes upon High-Fat Diet in Healthy Humans
Introduction and Objective: Hypercaloric nutrition may sequentially promote insulin resistance across tissues. Recent rodent studies indicate white adipose tissue (WAT) as key driver of whole-body insulin resistance. Thus, we hypothesized that WAT may respond early to overnutrition-induced metabolic changes in humans.Methods: In a randomized, parallel-group study, young glucose tolerant volunteers consumed either an isocaloric (ID; […]
Read More105-OR: ADA Presidents' Select Abstract: Enhanced Dopamine and Opioid Receptor Target Engagement Predicts Neuropathic Pain Treatment Response—A Resting-State fMRI Study in Painful Diabetic Neuropathy
Introduction and Objective: Painful diabetic neuropathy (DN) is a common and challenging complication of diabetes with limited treatments. Our research reveals that treatment responders show enhanced connectivity between the insula and corticolimbic systems, modulated by dopamine and opioid receptors. These findings highlight potential mechanisms of treatment efficacy and pathways for novel therapeutic development.Methods: 43 participants […]
Read More2159-LB: Hepatic PAQR4 Contributes to Metabolic Regulation by Mediating Ceramide Levels and Hepatokine Signaling
Introduction and Objective: PAQR4, an orphan receptor within the progestin and adipoQ receptor family (PAQR1-11), is implicated in multiple cancers, including hepatocellular carcinoma (HCC). However, its metabolic function in hepatocytes remains unclear. Our recent findings identify PAQR4 as a key regulator of ceramide metabolism. In adipocytes, PAQR4 overactivation leads to ceramide accumulation, disrupting adipose tissue […]
Read More1006-P: Developing CGMap—Characterizing Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes
Introduction and Objective: To characterize continuous glucose monitoring (CGM) data in patients with type 2 diabetes (T2D), and to assess the relationship between CGM-derived indicators and diabetes-related clinical parameters.Methods: The data was collected from a randomized trial in China (ChiCTR2000039424), in which patients with T2D wore CGM and received acarbose or sitagliptin. Ordinary least square […]
Read More